IGF1 and lung adenocarcinoma: The data show that IGF-1 reduces the activity of PKM2 in ARPE-19 cells, consistent with our previous observations in a human lung adenocarcinoma cell line, suggesting that activation of IGF1R signaling is associated with a decreased activity of the pyruvate kinase enzyme across multiple cell types.